Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
A Multicenter, Open-Label, Single-Arm Study to Evaluate a Titration Regimen for Patiromer in Heart Failure Patients With Chronic Kidney Disease
Sponsor: Relypsa, Inc.
Listed as NCT01130597, this PHASE2 trial focuses on Heart Failure and remains completed. Sponsored by Relypsa, Inc., it has been updated 7 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Relypsa, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Golnik, Slovenia
- • Izola, Slovenia
- • Ljubljana, Slovenia
- • Maribor, Slovenia
- • Slovenj Gradec, Slovenia
- • Tbilisi, Georgia